Latest news

• NICE backs constipation treatment

  Sucampo’s Amitiza set for NHS use in England and Wales. Sucampo's constipation treatment Amitiza (lubiprostone) should be available on the NHS, according to new healthcare guidance. ... Amitiza has been available in the UK since December last, but the

• AZ drug for opioid constipation starts FDA review

  Naloxegol on course to compete with Takeda’s Amitiza. AstraZeneca (AZ) took a step closer to securing US approval for its new candidate for opioid drug-induced constipation (OIC) after the ... Sucampo reported Amitiza sales of a little over $80m in

• An unexpected turn

  Lubiprostone. Amitiza (Takeda Pharmaceuticals). Irritable Bowel Syndrome. US. Mycophenolate mofetil (Cellcept; Roche) is an immunosupressant commonly used for treating and preventing transplant rejection.

• Sucampo moves on EU market

  US pharmaceutical company, Sucampo, has launched a bid to compete in the European marketplace by filing a marketing authorisation application in Switzerland for its drug, Amitiza. ... Nine other EU countries are currently reviewing MAAs for Amitiza,

• IBS drug approved in the US

  The US Food and Drug Administration has approved Amitiza for an additional indication to treat irritable bowel syndrome with constipation. ... The US Food and Drug Administration (FDA) has approved Amitiza for an additional indication to treat irritable